Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological groupWESTHOFF, G; RAU, R; ZINK, A et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 6, pp 849-854, issn 1462-0324, 6 p.Article

The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort studyKYBURZ, Diego; GABAY, Cem; MICHEL, Beat A et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 6, pp 1106-1110, issn 1462-0324, 5 p.Article

Anti-inflammatory activity of Terminalia paniculata bark extract against acute and chronic inflammation in ratsTALWAR, Sahil; NANDAKUMAR, K; NAYAK, Pawan G et al.Journal of ethnopharmacology. 2011, Vol 134, Num 2, pp 323-328, issn 0378-8741, 6 p.Article

Anti-inflammatory, anti-nociceptive, and anti-psychiatric effects by the rhizomes of Alpinia officinarum on complete Freund's adjuvant-induced arthritis in ratsJISUK LEE; KYOUNG AH KIM; SEONHUI JEONG et al.Journal of ethnopharmacology. 2009, Vol 126, Num 2, pp 258-264, issn 0378-8741, 7 p.Article

British society for rheumatology and british health professionals in rheumatology guideline for the management of rheumatoid arthritis (the first two years)LUQMANI, R; HENNELL, S; MOHAMMED, R et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 9, pp 1167-1169, issn 1462-0324, 3 p.Article

Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritisRANTALAIHO, V; PUOLAKKA, K; KORPELA, M et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S27-S31, SUP73Article

Psoriatic arthritis: current therapy and future directionsHUYNH, Doquyen; KAVANAUGH, Arthur.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 13, pp 1755-1764, issn 1465-6566, 10 p.Article

British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years)LUQMANI, Raashid; HENNELL, Sheena; GOODSON, Nicola et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 4, pp 436-439, issn 1462-0324, 4 p.Article

Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remissionJURGENS, M. S; WELSING, P. M. J; JACOBS, J. W. G et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S56-S63, SUP73Article

Treatment of pregnant and non-pregnant rheumatic patients : a survey among Dutch rheumatologistsVROOM, F; VAN DE LAAR, M. A. J. F; VAN ROON, E. N et al.Journal of clinical pharmacy and therapeutics (Print). 2008, Vol 33, Num 1, pp 39-44, issn 0269-4727, 6 p.Article

Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid populationGRIJALVA, C. G; CHUNG, C. P; STEIN, C. M et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 7, pp 1061-1064, issn 1462-0324, 4 p.Article

Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugsHUYNH, O. A; HAMPARTZOUMIAN, T; ARM, J. P et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 5, pp 742-751, issn 1462-0324, 10 p.Article

Ethnic differences in responses to disease modifying drugsHELLIWELL, P. S; IBRAHIM, G.Rheumatology (Oxford. Print). 2003, Vol 42, Num 10, pp 1197-1201, issn 1462-0324, 5 p.Article

The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytesKUSABE, Takuma; WAGURI-NAGAYA, Yuko; TANIKAWA, Tomohiro et al.Rheumatology international (Berlin. Print). 2005, Vol 25, Num 8, pp 625-630, issn 0172-8172, 6 p.Article

Glucocorticoid use in rheumatoid arthritis: Benefits, mechanisms, and risksTOWNSEND, H. B; SAAG, K. G.Clinical and experimental rheumatology (Testo stampato). 2004, Vol 22, Num 5, pp 77-82, issn 0392-856X, 6 p., SUP35Article

The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990―2010: before and after introduction of biologic agentsHALLERT, Eva; HUSBERG, Magnus; BERNFORT, Lars et al.Rheumatology (Oxford. Print). 2012, Vol 51, Num 2, pp 338-346, issn 1462-0324, 9 p.Article

Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritisAGARWAL, S; ZAMAN, T; HANDA, R et al.Singapore medical journal. 2009, Vol 50, Num 7, pp 687-693, issn 0037-5675, 7 p.Article

Magnetic resonance imaging is more sensitive than radiographs in detecting change in size of erosions in rheumatoid arthritisCHEN, Timothy S; CRUES, John V; ALI, Muhammad et al.Journal of rheumatology. 2006, Vol 33, Num 10, pp 1957-1967, issn 0315-162X, 11 p.Article

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawalCHOY, E. H. S; SMITH, C; DORE, C. J et al.Rheumatology (Oxford. Print). 2005, Vol 44, Num 11, pp 1414-1421, issn 1462-0324, 8 p.Article

Methotrexate in Rheumatoid Arthritis: Optimizing Therapy Among Different Formulations. Current and Emerging ParadigmsCIPRIANI, Paola; RUSCITTI, Piero; CARUBBI, Francesco et al.Clinical therapeutics. 2014, Vol 36, Num 3, pp 427-435, issn 0149-2918, 9 p.Article

Payers' views on treating-to-target in rheumatoid arthritis: an English perspectiveSCOTT, I. C; WAILOO, A; SCOTT, D. L et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4, issn 0392-856X, S85-S90, SUP73Article

Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis : the ERAN cohortKIELY, P; WILLIAMS, R; WALSH, D et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 1, pp 57-60, issn 1462-0324, 4 p.Article

Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drugHYRICH, K. L; LUNT, M; DIXON, W. G et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 7, pp 1000-1005, issn 1462-0324, 6 p.Article

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritisNELL, V. P. K; MACHOLD, K. P; EBERL, G et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 7, pp 906-914, issn 1462-0324, 9 p.Article

Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential StudyIANNACCONE, Christine K; LEE, Yvonne C; JING CUI et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 1, pp 40-46, issn 1462-0324, 7 p.Article